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Edited by Veli-Pekka LehtoAbstract Cardiac b-adrenergic and the muscarinic receptors
control contractility and heart rate by triggering multiple signal-
ing events involving downstream targets like the phosphoinositide
3-kinase c (PI3Kc). We thus investigated whether the lack of
PI3Kc could play a role in the autonomic regulation of the mouse
heart. Contractility and ICaL of mutant cardiac preparations ap-
peared increased in basal conditions and after b-adrenergic stim-
ulation. However, basal and b-adrenergic stimulated heart rate
were normal. Conversely, muscarinic inhibition of heart rate
was reduced without alteration of the Gbc-dependent stimulation
of IK,ACh current. In addition, muscarinic-mediated anti-adrener-
gic eﬀect on papillary muscle contractility and ICaL was signiﬁ-
cantly depressed. Consistently, cAMP level of PI3Kc-null
ventricles was always higher than wild-type controls. Thus,
PI3Kc controls the cardiac function by reducing cAMP concen-
tration independently of Gi-mediated signaling.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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receptor; cAMP1. Introduction
In the cardiovascular system, homeostatic regulation is
mainly controlled by the extracellular signals transduced by
G protein-coupled receptors (GPCRs). Sympathetic and para-
sympathetic transmitters act on cardiac GPCRs to modulate
heart rate and contractility [1]. In the heart, the predominant
receptors for the sympathetic agonists belong to the b-adrener-
gic receptor (b-AR) family comprising three isoforms desig-
nated b1, b2 and b3. On the other hand, the parasympathetic
cholinergic action is mainly mediated by the M2 muscarinic
receptor [1]. Stimulation of these receptors leads to the disso-
ciation of trimeric G proteins into Ga and Gbc subunits that
in turn trigger a complex signaling cascade. Most b-ARs, like*Corresponding author. Fax: +39 011 670 6547.
E-mail address: emilio.hirsch@unito.it (E. Hirsch).
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doi:10.1016/j.febslet.2004.11.059the b1 receptor, are coupled to Gas, which increases heart rate
and contractility through the activation of adenylyl cyclase.
The increased intracellular concentration of cAMP activates
protein kinase A, which phosphorylates troponin I, the L-type
Ca2+-channel and phospholamban. These processes can be
contrasted by the antiadrenergic eﬀect of the M2 muscarinic
receptor, which couples to Gai and thus promotes a decrease
of intracellular cAMP [2]. Concomitantly with the eﬀects of
Gai, the activation of the M2 receptor also causes the release
of the Gbc subunits and their direct activation of the GIRK
potassium channels, that contribute to cardiomyocyte hyper-
polarization and reduction of heart rate [3].
In the heart, Gbc subunits are also thought to activate phos-
phoinositide 3-kinases (PI3Ks), a family of protein and lipid
kinases involved in multiple biological processes including cell
proliferation and survival, cytoskeletal remodeling and mem-
brane traﬃcking [4]. Based on their biochemical properties,
these enzymes are divided into three classes and at least three
members (a, b and c) of class I PI3Ks are expressed in the
mammalian heart [5]. While PI3Ka and b (class IA PI3Ks)
associate to p85-like regulatory proteins docking to phosphor-
ylated tyrosines in YXXMmotives, PI3Kc (the unique class IB
PI3K) binds directly or in association with the p101 adaptor to
the bc subunits of G proteins and is thus activated by GPCRs
[6].
Indirect evidence suggests that the class IB PI3Kc can be
stimulated by Ca2+/PKC [7] or prototype cardiac GPCRs,
such as adrenergic and muscarinic receptors. In transfected
ﬁbroblasts, PI3Kc is activated by b-ARs and contributes to
their desensitization through the membrane targeting of a
b-AR kinase (bARK)-PI3Kc cytoplasmic complex [8]. More-
over, ectopic expression of both M2 receptor and PI3Kc in
COS-7 cells causes a muscarinic agonist-dependent PI3Kc
stimulation and the consequent activation of the protein ki-
nase B/Akt [9] and MAPK [10]. Interestingly, PI3Kc activity
appears to be upregulated in vivo in the mouse model of
pressure overload hypertrophy induced by transverse aortic
constriction [11].
We and others recently reported the generation of PI3Kc-
deﬁcient mice. These mutant mice are viable and fertile, but dis-
play defective GPCR-mediated responses to chemoattractants
in leukocytes [12–14], to ADP in platelets [15] and to adenosine
in mast cells [16]. On the other hand, cardiomyocytes derivedblished by Elsevier B.V. All rights reserved.
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reduction of the spontaneous Ca2+ spiking induced by ATP
[17]. Furthermore, both in vivo echocardiographic analysis
and in vitro studies on isolated myocardial cells indicate that
the lack of PI3Kc causes enhanced cardiac contractility [18].
This eﬀect is correlated to an involvement of PI3Kc on cAMP
homeostasis: in fact, isolated PI3Kc-null cardiomyocytes in ba-
sal conditions and after stimulation with the b2-AR-speciﬁc
agonist zinterol produced signiﬁcantly higher levels of cAMP
than wild-type controls.
Here, we further explored the role of PI3Kc in the auto-
nomic control of heart function and found that the lack of
PI3Kc not only aﬀects b-adrenergic signaling but also musca-
rinic-dependent responses. In PI3Kc-deﬁcient mice, while iso-
proterenol (Iso) caused a stronger enhancement of
contractility, carbachol (CCh) unexpectedly induced a weaker
chronotropic eﬀect. Similarly, the anti-adrenergic activity
caused by cholinergic stimulation was reduced in mutant
cardiomyocytes. In PI3Kc-null papillary muscles, b-adrenergic
receptor desensitization was normal and, in ventricular myo-
cytes, the muscarinic regulation of potassium ion channels
was unaltered. Nevertheless, cAMP levels appeared higher in
mutant hearts than wild-type controls in all conditions tested.
Our data thus indicate that PI3Kc modulates cardiac function
by reducing cAMP concentration through a mechanism that is
independent of receptor internalization or Gi-dependent
signaling.2. Materials and methods
2.1. Mice
PI3Kc-deﬁcient mice (PI3Kc/) and ‘‘knock-in’’ mutants express-
ing a catalytically inactive PI3Kc (PI3KcKD/KD) mice were obtained
as previously described [12,19]. All experiments were performed with
sex matched 8-week-old wild-type and PI3Kc/ mice; both mutant
and control animals (PI3Kc+/+) were inbred 129sv or littermates from
heterozygous crosses. Animal experiments and sacriﬁces were carried
out in compliance with institutional guidelines as well as with Italian
and Swiss government regulations and under local ethical committee
guidance.
2.2. In vivo experiments
In vivo analysis of cardiovascular responses to diﬀerent agonists was
performed in Pentobarbital sodium (40 mg/kg in saline) anesthetized
mice. Animals were placed on a heating pad at 37 C; heart rate was
analyzed by standard electrocardiographic (ECG) techniques. For
agonist administration, a Teﬂon tubing was inserted in the left jugular
vein and a bolus of 100 ll of agonist or saline alone was administered
within 30 s. Doses of isoproterenol (3 lg/kg) and carbachol (8 lg/kg)
were chosen as previously described [20,21].
2.3. Analysis of spontaneous beating frequency in right atrium muscle
and contractility in isolated papillary muscle
After sacriﬁce, heart was rapidly removed, and right atria or papil-
lary muscles from left ventricle were dissected free under microscopic
control. Atria and papillary muscles were perfused with a modiﬁed
Tyrode solution (154 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 5.5 mM D-glucose, and 5 mM HEPES, adjusted to pH 7.38
with NaOH and gassed with 100% O2). Atria and papillary muscles
were equilibrated in modiﬁed Tyrode solution for at least 30 min;
experiments were conducted at 37 C. Isolated, spontaneously beating
right atria and papillary muscles were used to study the chronotropic
and inotropic responses, respectively. Papillary muscles were driven
at a frequency of 240 beats/min with a pair of electrodes connected
to a 302 T Anapulse Stimulator via a 305-R Stimulus Isolator (W.P.
Instruments, New Haven, CT), operating in constant current mode.Isometric twitches were measured by a Harvard Isometric Transducer
60–2997, recorded and analyzed by a Power Mac computer using cus-
tom programmed Labview Software (National Instruments, Texas,
USA). All drug-containing solutions were prepared fresh before the
experiments. Desensitization to repeated b-adrenergic stimulations
was studied in papillary muscles of both wild-type and PI3Kc-deﬁcient
mice according to the following protocol: after equilibration, papillary
muscles were stimulated three times with Iso (1 lM) for 5 min. During
the interval between each period of stimulation, papillary muscles were
washed with Tyrode solution for diﬀerent times, lasting for 10 or 30
min, respectively, between the ﬁrst and the second, or the second
and the third period.2.4. Isolation of cardiomyocytes and patch clamp analysis
Isolated ventricular cells were obtained from adult mice by enzy-
matic dissociation after animal killing under anesthesia and heart
explantation. Brieﬂy, after cannulation of ascending aorta, hearts were
perfused with Tyrode Calcium Free solution (containing, in mM: 135
NaCl, 4 KCl, 1 MgCl2, 2 HEPES, 10 glucose, 10 butanedione monox-
ime, and 5 taurine; pH 7.40, adjusted with NaOH) for 5 min (37 C)
and then with 10 ml of Tyrode Calcium Free with collagenase (0.3
mg/ml) and protease (0.02 mg/ml). Hearts were then perfused and
enzymatically dissociated with 30 ml of Tyrode solution containing
50 lM CaCl2 and the same concentrations of enzymes, as mentioned
before. Atria and ventricles were then separated and the ventricles were
cut in small pieces and shaken for 10 min in 20 ml of Tyrode Calcium
Free in the presence of 50 lMCaCl2, collagenase and protease. Whole-
cell patch clamp experiments were performed at 30 C. The whole-cell
patch clamp standard solution contained (mM): 133 CsCl; 5 EGTA
free acid; 5 Na2ATP; 5 Na2phosphocreatine; 5 HEPES; 3 MgCl2;
and 0.4 Na2GTP; pH 7.3, adjusted with CsOH. Isolated ventricular
cells were continuously bathed with Cesium Tyrode solution (contain-
ing, in mM: 138 NaCl, 20 CsCl, 2 CaCl2, 1 MgCl2, 5.5 D-glucose, 1 4-
aminopyridine, and 5 HEPES, pH 7.35, adjusted with NaOH); test
solutions were applied through ﬁne silicon tubes. To measure ICaL,
the cell was depolarized every 5 s from 100 to 40 mV for 50 ms,
to inactivate both sodium current and T-type calcium current. All
drug-containing solutions were prepared fresh before the experiments.
Cell capacitance was measured using the standard procedures de-
scribed in the Axopatch (Axon) manual.
For the measure of acetylcholine-activated potassium currents, the
extracellular solution contained (mM): 120 NaCl; 20 KCl; 1 MgCl2;
and 10 HEPES; pH 7.40, adjusted with NaOH. The intracellular
solution contained (mM): 100 Kaspartate; 40 KCl; 5 MgCl2;5
Na2ATP; 2 EGTA; 0.01 GTP; and 5 HEPES; pH 7.40, adjusted with
KOH [22].
To measure inward rectifying potassium currents, the membrane po-
tential was held at 90 mV and then driven from 120 to +60 mV with
a slope of 1 mV/ms. IK,ACh was computed as the diﬀerence current be-
tween CCh treatment and control. The diﬀerence current was then
evaluated at 70 mV after subtraction of the current at its theoretical
reversal potential (50 mV with the solutions described above) [22].
2.5. cAMP measurement in isolated hearts
Isolated mouse hearts were mounted on a Langendorﬀ perfusion
apparatus, and perfused at a constant ﬂow rate using a peristaltic
pump with modiﬁed Tyrode solution warmed to 37 C and gassed with
100% O2. After stabilization, the hearts were subjected to stimulation
with 1lM Iso perfused alone or together with 1 lM CCh for 1 min.
After stimulation, ventricles were removed and frozen in liquid nitro-
gen. Tissue cAMP levels were measured with a radiolabeled competi-
tive protein-binding assay (Cyclic AMP [3H]BiotrakTM Assay
System, Amersham Biosciences, Piscataway, USA). For assessing the
role of Gi in cAMP metabolism, mice were treated i.p. with 100 lg/
kg of Pertussis Toxin (Sigma, St. Louis, MO) as previously described
[19]. The eﬀect of pertussis toxin was tested 16 hours later for its ability
to block the muscarinic chronotropic response by ECG measurement.
2.6. Statistical analysis
Data are expressed as means ± S.E.M. Comparison between groups
was performed using two-way ANOVA for repeated measures (in vivo
studies) or one way ANOVA (in vitro measurements), followed by
Bonferroni post hoc test. Statistical signiﬁcance was assigned to P va-
lue <0.05.
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3.1. Increased positive inotropism, but no diﬀerence in the
chronotropic eﬀect after b-adrenergic stimulation of
PI3Kc-null hearts
In the heart, stimulation of b-adrenergic receptors in-
creases contractility as well as beating frequency. We thus
evaluated whether the lack of PI3Kc could aﬀect b-AR-
dependent enhancement of heart rate and force development
both in vivo and in isolated cardiac preparations. PI3Kc-
deﬁcient (PI3Kc/) and wild-type (PI3Kc+/+) mice showed
comparable basal values for heart rate (450 ± 8 and
409 ± 18 beats/min, n = 3 and n = 4 in PI3Kc+/+ and
PI3Kc/; respectively). The b-adrenergic-dependent positive
chronotropism induced by intravenous administration of iso-
proterenol (single bolus dose, 3 lg/kg) showed an identical
increase in the heart rate of both wild-type and mutant ani-
mals (Fig. 1A). Similarly, we observed no signiﬁcant diﬀer-
ence in spontaneous beating frequency (203 ± 16 and
190 ± 40 beats/min; n = 4 in both cases) as well as in the po-
sitive chronotropic eﬀect induced by Iso (1 lM) on both
PI3Kc+/+ and PI3Kc/ isolated right atria (44.2 ± 15.9
and 36.1 ± 9.1% increase over basal values) (Fig. 1B).
Positive inotropism caused by b-adrenergic stimulation with
isoproterenol was next examined in electrically driven papil-
lary muscles. As expected from previous indications [18,19],
in basal conditions papillary muscles from mutant mice
showed an enhanced contractility in comparison with control
preparations (1.9 ± 0.3 vs. 3.3 ± 0.4 mN/g tissue wet weight
for wild-type and PI3Kc-deﬁcient samples, respectively; n = 7
and 12; P < 0.05 by ANOVA; Fig. 2A and C). Moreover,
PI3Kc-deﬁcient papillary muscles showed a more prominent
response to b-adrenergic stimulation, which was 80% stronger
than that detected in wild-type controls (Fig. 2B and D). As
shown in Fig. 2E, the inotropic eﬀect of Iso (1lM) was signif-
icantly higher in PI3Kc-null papillary muscles (524.0 ± 65.5%
of basal value, n = 16), than in wild-type preparations
(337.5 ± 33.5% of basal value, n = 15; P < 0.01 by ANOVA).Fr
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Fig. 1. The lack of PI3Kc has no eﬀects on b-adrenergic chronotropic
stimulation. (A) Heart rate after intravenous administration of 3 lg/kg
isoproterenol in anesthetized animals. White diamonds, wild-type;
black squares, PI3Kc/; values are expressed as % of basal heart rate.
Isoproterenol was administered at time 0. (B) Right atrium beating
frequency 30 s after administration of 1 lM isoproterenol. Bars (white,
wild-type; black, PI3Kc/) represent the% of basal values. Basal
values for both spontaneous beating frequency (203 ± 16 and 190 ± 40
beats/min, wild-type and PI3Kc/, respectively; n = 4 in both cases)
were not signiﬁcantly diﬀerent.Since it has been suggested that PI3Kc could be involved in
b-adrenergic receptors internalization [5], we studied the re-
sponse of papillary muscle to repeated stimulations with Iso
(1 lM). No signiﬁcant diﬀerence between control and mutant
papillary muscles was detected for the reduced response to Iso
10 min after a previous stimulation (50.3 ± 8.9 and 55.1 ± 6.2%
of the eﬀect induced by the ﬁrst stimulation with Iso, n = 4 and
5), as well as for the recovery after 30 min washout interval
(79.0 ± 5.1 and 81.4 ± 10.0% of the eﬀect induced by the ﬁrst
stimulation with Iso, n = 4 and 5), thus suggesting that the
absence of PI3Kc does not alter b-adrenergic receptors
desensitization.
The increased contraction in response to isoproterenol is
considered a consequence of b-AR-induced elevation of
cAMP, PKA activation and subsequent phosphorylation of
contraction-controlling proteins, including voltage-dependent
L-type Ca2+ channels. Phosphorylation of these channels pro-
motes Ca2+ inﬂux that triggers the release of intracellular Ca2+
from the sarcoplasmic reticulum. The subsequent intracellular
Ca2+ transient ﬁnally activates the contraction of myoﬁla-
ments. Patch clamp experiments revealed that, although no
signiﬁcant diﬀerence in cell capacitance was found between
wild-type and PI3Kc/ ventricular cells (189.77 ± 17.18 pF,
n = 34 and 180.73 ± 13.90 pF, n = 27 respectively), calcium
current density in the absence of stimulation was higher in
PI3Kc/ cells (wild-type: 4.31 ± 0.51 pA/pF, n = 34; PI3Kc-
null: 5.92 ± 0.53 pA/pF, n = 27; P < 0.05). Consistently,
PI3Kc/ cardiac myocytes showed abnormally increased L-
type Ca2+ current in basal conditions (ICaL, Fig. 3A–D, arrows
#1 and 2) as well as in response to isoproterenol stimulation
(70% increase after 1lM isoproterenol, P < 0.01, Fig. 3E).
These data thus show that PI3Kc negatively regulates L-type
Ca2+ current before and after b-adrenergic stimulation. To
study if the higher basal values of calcium current were due
to cAMP-dependent phosphorylation, the PKA inhibitor
H89 (1 lM) was used. In this condition, the reduction of cal-
cium current density in cardiac cells from PI3Kc/ mice ap-
peared stronger (74.47 ± 4.47%; n = 6) than that detected in
wild-type controls (39.40 ± 8.91%; n = 5). The calcium current
density, which in basal conditions was higher in PI3Kc/ cells
(PI3Kc+/+: 3.65 ± 0.25 pA/pF (n = 5); PI3Kc/: 6.99 ± 1.10
pA/pF (n = 6); P < 0,05), became comparable in both geno-
types after H89 administration (PI3Kc+/+: 2.66 ± 0.25 pA/
pF; PI3Kc/: 3.98 ± 0.63 pA/pF).
3.2. Reduced muscarinic inhibition of heart rate in PI3Kc-null
mice
To study the role of PI3Kc in cholinergic signaling, heart
rate was evaluated in anesthetized PI3Kc-null and wild-type
mice before and after intravenous administration of carbachol
(8 lg/kg, single bolus dose). In basal conditions, wild-type and
PI3Kc-null mice did not show signiﬁcant diﬀerences in heart
rate (432 ± 12 and 474 ± 27 beats/min, n = 5 for both cases).
Furthermore, intravenous administration of saline did not
cause diﬀerent responses in mice of the two genotypes (not
shown). After infusion of carbachol into the jugular vein,
wild-type animals exhibited a dramatic drop in heart rate;
however, this eﬀect was signiﬁcantly reduced in mice lacking
PI3Kc. At 40 s after stimulation, when the eﬀect of carbachol
reached its peak, heart rate of PI3Kc-null mice was 40% higher
than that of wild-type controls (150 ± 59 and 372 ± 42 bpm for
wild-type and PI3Kc/ mice, respectively; P < 0.001; Fig. 4).
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chronotropism, we next tested whether the impaired musca-
rinic response detected in vivo could be conﬁrmed in explanted
cardiac preparations. In unstimulated, spontaneously beating
isolated right atria, baseline frequency was similar in both
genotypes (264.2 ± 26.7 and 233.0 ± 23.2 beats/min, wild-type
and PI3Kc/, respectively; n = 4 in both groups). Carbachol
(1 lM), however, depressed heart rate less extensively inPI3Kc-null than in wild-type right atria (88.2 ± 7.0% inhibi-
tion in wild-type, n = 4; 56.8 ± 9.3% in PI3Kc-null, n = 4;
P < 0.05, Fig. 5). These data thus indicate that control of mus-
carinic-induced negative chronotropism can be aﬀected by the
lack of PI3Kc.
These results suggested that the eﬀect of the lack of PI3Kc
on cardiac cAMP levels could be responsible for the reduced
responsiveness to muscarinic agonists. As the expression in
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Fig. 4. In vivo chronotropic eﬀect of carbachol. Wild-type, empty
diamonds; PI3Kc/, ﬁlled squares. CCh (8 lg/kg) was administered
i.v. at time 0. Heart rate was obtained from ECG recording. Basal
values for heart rate (432 ± 12 beats/min, wild-type, n = 5 and 474 ± 27
beats/min, PI3Kc/, n = 5) were superimposable. Statistical diﬀerence
of wild-type vs. mutant: * P < 0.05; ** P < 0.01 by ANOVA with
Bonferroni pair-wise comparison.
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increased cAMP levels and contractility seen in PI3Kc-null
heart [19], we tested the negative chronotropic eﬀect of
CCh on PI3KcKD/KD hearts. Isolated right atria from
PI3KcKD/KD mice showed a spontaneous beating frequency
(245.8 ± 13.3, n = 5) and a negative chronotropic eﬀect of
CCh (86.5 ± 2.7% inhibition), which were fully comparable
to those found in WT preparations. This ﬁnding indicates that
the reduced response to muscarinic modulation is not due to
the kinase activity of PI3Kc.
3.3. Stimulation of IK,ACh after cholinergic stimulation is not
aﬀected by the lack of PI3Kc
Heart rate is known to be negatively controlled mainly by
the muscarinic receptor-dependent activation of the IK,ACh
potassium current. To investigate whether eﬀects on IK,ACh
were involved in the reduced muscarinic inhibition of heart
rate observed in PI3Kc-null mice, we studied the muscarinic
modulation of IK,ACh in isolated atrial cells. The absence of
PI3Kc did not aﬀect the entity of the potassium current in-
duced by CCh (1 lM) measured at 70 mV (58.7 ± 4.2 vs.E
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min, wild-type and PI3Kc/, respectively; n = 4 in both groups) and con
diﬀerent.73.3 ± 12.2 pA/pF, n = 7 and 5 in wild-type and PI3Kc-deﬁ-
cient cells, respectively), thus indicating that the lack of PI3Kc
does not alter Gi activation and that PI3Kc controls heart rate
independently of potassium current and Gbc-dependent signal
transduction events.
3.4. The muscarinic antiadrenergic eﬀect in papillary muscles
and isolated cardiomyocytes is reduced in the absence of
PI3Kc
In the mouse, muscarinic stimulation is known to be unable
to aﬀect contractility of ventricular muscle, in the absence of a
previous enhancement of cAMP intracellular concentration
[2]. In agreement, we did not observe signiﬁcant eﬀects of car-
bachol (1 lM) on contractile force developed by papillary
muscles of both genotypes in basal conditions (Table 1). Since
it has been shown that muscarinic agonists exert an indirect
depression of ventricular muscle contractility after b-adrener-
gic stimulation [23], we studied the antiadrenergic eﬀect of
CCh (1 lM) in the presence of Iso (1 lM). In these conditions,
the lack of PI3Kc signiﬁcantly reduced the negative inotropic
response to muscarinic stimulation (Table 1). In agreement
with the results obtained in papillary muscle, we observed that
CCh (1 lM) had not signiﬁcant eﬀect on baseline values of L-
type calcium current in cells from both PI3Kc+/+ and PI3Kc/
mice, and that the antiadrenergic eﬀect of CCh (1 lM) was sig-
niﬁcantly reduced in PI3Kc-null ventricular cells (96.3 ± 16.9
and 47.6 ± 12.0% of the enhancement induced by Iso in wild-
type and PI3Kc-deﬁcient, respectively; n = 12 and 8, P < 0.05
by ANOVA; Fig. 3A–D).
As L-type Ca2+ channels are controlled by PKA, we mea-
sured the levels of cAMP in wild-type and PI3Kc-deﬁcient
hearts before and after stimulation with Iso and the combina-
tion of Iso/CCh. In agreement with previous reports [18], the
basal levels of cAMP were signiﬁcantly higher in mutant than
in controls (Fig. 6). Nonetheless, this diﬀerence was still detect-
able after both Iso and Iso/CCh stimulation, where cAMP in
PI3Kc-null hearts was 40% and 50% higher than controls,
respectively (Fig. 6). Remarkably, the percentage inhibition
of cAMP concentration induced by CCh was signiﬁcantly*
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Table 1
Direct and antiadrenergic eﬀects of carbachol on papillary muscle
contraction
Wild-type PI3Kc/
Direct Eﬀecta
CCh 1 lM 110.1 ± 10.3 (4) 108.3 ± 5.9 (4)
Antiadrenergic Eﬀectb
CCh 1 lM 73.7 ± 5.6 (4) 13.2 ± 12.1 (4)*
Values are represented as means ± SEM.
aValues are expressed as percentage of basal contractility.
bValues are expressed as percentage reduction of isoproterenol (1 lM)
eﬀect.
*P < 0.01 (Wild-type vs. PI3Kc/). The number of individual samples
analyzed is indicated in brackets.
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Fig. 6. Total cAMP concentration in wild-type and mutant hearts.
Levels of cAMP (wild-type, white bars; PI3Kc/, black bars)
measured by standard radioactive assay in Langendorﬀ-perfused
hearts before and after 1 min of stimulation with Iso (1 lM) or CCh
(1 lM) or their combination (for each bar n = 6, *P < 0.05, **P < 0.01,
***P < 0.001 by ANOVA).
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23 ± 4%, respectively; n = 6, P < 0.001 by Students t test).
Stimulation with Iso/CCh after overnight pretreatment of
hearts with 100 lg/kg of pertussis toxin did not cause any
change in the levels of cAMP detected with Iso alone (data
not shown). These data thus show that the reduced antiadren-
ergic response, detected in mutant hearts, is due to an abnor-
mally elevated cAMP concentration and that PI3Kc controls
cAMP levels independently of Gi-mediated signaling.4. Discussion
Here, we reported that the eﬀect of b-adrenergic stimulation
on spontaneous heart rate was similar in both wild-type and
PI3Kc-null mice and isolated atria. However, the b-adrener-
gic-mediated enhancement of contractile force induced by Iso
was signiﬁcantly higher in PI3Kc-deﬁcient papillary muscles.
In murine cardiac myocytes, the major receptors for catechol-
amines are the b1 and b2-ARs [1,2]. Being the b1-AR the un-
ique responsible for modulation of pacemaker activity [20],this ﬁnding suggests that the loss of PI3Kc might not aﬀect
b1-AR signal transduction. As previously indicated [18], our
data further suggest that the lack of PI3Kc might unmask
the activity of b2-AR. It has been indeed reported that the
b2-AR speciﬁc agonist zinterol, which is inactive on wild-type
cardiac cells, causes increased enhancement of cAMP produc-
tion and phospholamban phosphorylation in PI3Kc-deﬁcient
cardiomyocytes [18]. To control cAMP levels, PI3Kc associ-
ates with the PDE3B phosphodiesterase and positively modu-
lates its activity in kinase independent way [19]. Our data
extend these results providing the evidence that the increase
in ventricular cAMP concentration perfectly correlates with
the increase in calcium current density. Although PI3Kc was
previously reported to activate L-type Ca2+ channels in vascu-
lar smooth muscle cells by the activation of PKC [24,25], our
observations strongly suggest that the higher contractility of
PI3Kc hearts is most likely due to abnormally high levels of
cAMP that through the activation of PKA cause increased
open probability of L-type channels.
An alternative explanation of the increased positive inotro-
pic eﬀect observed in isoproterenol-stimulated mutant papil-
lary muscles is based on a defective receptor desensitization.
It has been indeed suggested that PI3Kc is involved in these
processes and favors b-AR desensitization by internalization
[26]. However, our data, showing no signiﬁcantly diﬀerent re-
sponses between wild-type and PI3Kc-deﬁcient papillary mus-
cles to repeated stimulation with Iso, suggest that the in vivo
absence of PI3Kc does not inﬂuence b-AR desensitization.
This is in agreement with the observation that the lack of
PI3Kc or the alteration of PtdIns(3,4,5)P3 production does
not modify baseline expression of cardiac b-ARs [18] even
after prolonged exposure to isoproterenol [27]. Furthermore,
it has been reported that other class IA PI3K, like PI3Ka
can associate with b ARK and speciﬁcally compensate for
the lack of PI3Kc [28]. Overall, these data as well as our obser-
vations of increased cAMP, ICaL, and ventricular contractility
in basal conditions suggest, on the other hand, that PI3Kc af-
fects cardiac inotropism primarily through its action on cAMP
metabolism. Finally, the ﬁnding that inhibition of PKA abro-
gates the diﬀerence in baseline ICaL density strongly suggests
that this diﬀerence is due to cAMP-PKA dependent phosphor-
ylation of the channels, rather than an increased channel
expression.
Unexpectedly, however, our results clearly indicate that the
lack of PI3Kc also aﬀects the muscarinic-dependent cardiac re-
sponses. Indeed, we observed that muscarinic inhibition of
heart rate was reduced both in vivo and in isolated right atria
from PI3Kc-deﬁcient mice. Moreover, the anti-adrenergic ef-
fect of muscarinic stimulation on contractility and ICaL was
signiﬁcantly depressed.
Reduction of heart rate (negative chronotropism) and coun-
teraction of the enhanced contractility induced by adrenergic
agonists (indirect negative inotropism) are mainly controlled
by the Gai-coupled muscarinic receptor of the M2 subtype
[1,2]. The report of PI3Kc being downstream M2 receptor acti-
vation [10,29] suggested that this enzyme might play a role in
the muscarinic modulation of cardiac activity. In the mouse
heart, the muscarinic chronotropic response is primarily med-
iated by the Gi-coupled M2 receptor present in the sino-atrial
node [1,2,30]. This receptor can reduce heart rate by modulat-
ing at least two major signaling pathways: it can induce the
opening of a type of inward rectifying potassium current
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tion of the hyperpolarization-activated current (If). Our obser-
vation that muscarinic stimulation of IK,ACh current appeared
identical in mutant and wild-type atrial cardiomyocytes sug-
gests that PI3Kc is not involved in the muscarinic modulation
of this current. This ﬁnding is consistent with the fact that
IK,Ach is directly activated by binding of the bc subunits of
Gi to the GIRK potassium channels, while If, like L-type cal-
cium current, is controlled by cAMP levels [3,31]. In agreement
with this view, our data showed increased cAMP contents in
PI3Kc-null samples concomitantly stimulated with Iso and
CCh. Therefore, a likely explanation for the reduced musca-
rinic eﬀect is that an increase in the response to b-adrenergic
stimulation has partially overcome the inhibitory eﬀect of mus-
carinic receptor activation. This would indeed be expected be-
cause of the competitive nature of the interaction between the
two signaling pathways involved. Nevertheless, basal and
b-adrenergically stimulated heart rate are not altered in
PI3Kc-null mice, thus indicating that the increase in cAMP
concentration is compartmentalized and, in these conditions,
does not inﬂuence the pacemaker activity. The ﬁnding that
muscarinic anti-adrenergic eﬀect on cAMP levels of PI3Kc-
null cardiac samples is reduced indicates that PI3Kc inﬂuences
cAMP concentration independently of the action of Gi. As the
lack of PI3Kc does not aﬀect adenylate cyclase activity [19],
these further support the view that PI3Kc modulates cAMP
destruction through its positive eﬀect on PDE3B activity. It
is thus possible that the Gai-mediated inactivation of adenylate
cyclase could unmask a slower rate of cAMP destruction that
ﬁnally aﬀects frequency.
Taken together, our results conﬁrm and extend the notion
that PI3Kc is involved in the b-adrenergic-dependent control
of positive inotropism but not of positive chronotropism,
and suggest that this enzyme exerts its function independently
of receptor desensitization. Finally, our results indicate that
PI3Kc controls muscarinic autonomic cardiac regulation and
the muscarinic anti-adrenergic eﬀect, independently of Gi-med-
iated signaling and through its ability to downregulate cAMP
concentration.Acknowledgment: This work was supported by Human Frontier Sci-
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